- Science
- Global
Nanoparticle vaccine approach takes on a new target: Hepatitis C virus
- March 4, 2026 at 2:40 PM
- 1 views
Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a leading cause of cirrhosis and liver cancer. While antiviral drugs can cure most infections, global access remains limited and these drugs do not stop reinfection.
Originally published at Phys.org